Danish drugmaker Novo Nordisk revealed that it will soon be launching its long-lasting insulin injection, Tresiba, in India for type 1 and type 2 diabetes patients. The once-a-day jab can provide insulin action for up to 42 hours, allowing diabetics to day-to-day dosing time when needed without raising the risk of hypoglycaemia. The injection will come in form of a prefilled pen and can enable a dosage of up to 80 units in a single use. The company said that it will ...You have just read an article categorized health
titled Novo to Launch Once-a-Day Insulin Injection Tresiba in India.
Written by:
editor - Tuesday, September 3, 2013
There are currently no comments for "Novo to Launch Once-a-Day Insulin Injection Tresiba in India"
Post a Comment